Date of Conferral
5-8-2024
Date of Award
May 2024
Degree
Doctor of Nursing Practice (DNP)
School
Nursing
Advisor
Deborah Lewis
Abstract
Walden University College of Nursing This is to certify that the doctoral study by Nadine Mbou has been found to be complete and satisfactory in all respects, and that any and all revisions required by the review committee have been made. Review Committee Dr. Deborah Lewis, Committee Chairperson, Nursing Faculty Dr. Elizabeth Diener, Committee Member, Nursing Faculty Chief Academic Officer and Provost Sue Subocz, Ph.D. Walden University 2024 The burden of dyslipidemia among children has increased substantially, affecting approximately 7% of adolescents in the United States. Although pediatric dyslipidemia screening can promote early identification, a standardized clinical practice guideline (CPG) on pediatric dyslipidemia screening is lacking, which may contribute to minimal health care intervention and associated comorbidities in adult life. Guided by Watson’s theory of human caring, this project was conducted to develop an evidence-based CPG on pediatric dyslipidemia screening that could be validated using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. A literature review revealed nine relevant and peer-reviewed articles that were appraised and used to develop the new CPG. The newly developed CPG was then submitted to content experts who evaluated it using the AGREE II instrument, resulting in individual domain scores of 100%. The content experts recommended the newly developed CPG for use in guiding pediatric dyslipidemia screening. The newly developed CPG will guide health care providers on early screening of dyslipidemia for all children aged 9 to 11 years old to prevent the burden of dyslipidemia comorbidities as the children reach adulthood. Pediatric dyslipidemia screening could contribute to positive social change by reducing the burden of disease in the pediatric population by promoting timely screening and treatment of children identified to have pediatric dyslipidemia. Notably, screening for dyslipidemia in the pediatric population could safeguard children from cardiovascular health outcomes and reduce the burden of atherosclerosis and cardiovascular disease in adulthood.
Recommended Citation
Mbou, Nadine Touayem, "A Clinical Practice Guideline on Dyslipidemia Screening in Children" (2024). Walden Dissertations and Doctoral Studies. 15739.
https://scholarworks.waldenu.edu/dissertations/15739
